Long-term prognostic significance of HER-2/neu in untreated node-negative breast cancer depends on the method of testing.

Breast cancer research : BCR

Volumn 7, Issue 2, 2005, Pages

  Schmidt, Marcus ^a   Lewark, Barbara ^a   Kohlschmidt, Nikolai ^a   Glawatz, Christiane ^a   Steiner, Erik ^a   Tanner, Berno ^a   Pilch, Henryk ^a   Weikel, Wolfgang ^a   Kölbl, Heinz ^a   Lehr, Hans Anton ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ADULT; AGED; ARTICLE; BIOSYNTHESIS; BREAST TUMOR; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MIDDLE AGED; PATHOLOGY; PREDICTION AND FORECASTING; PROGNOSIS; REPRODUCIBILITY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHATIC METASTASIS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECEPTOR, ERBB-2; REPRODUCIBILITY OF RESULTS;

EID: 29844454750     PISSN: None     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr991     Document Type: Article

References (0)